IS-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IS-002, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: IS-002 Phase 2 Prostate Cancer Study [Phase 2]
1 regulatory and trial event tracked for IS-002, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: IS-002 Phase 2 Prostate Cancer Study [Phase 2]